Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Business Summary
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 3,738 | 100.0 % | 5,961 | 100.0 % | +59.47% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
89.2
%
| 3,303 | 88.4 % | 5,316 | 89.2 % | +60.92% |
North America
5.8
%
| 169 | 4.5 % | 348 | 5.8 % | +106.21% |
Asia Pacific (excluding China)
3.6
%
| 208 | 5.6 % | 214 | 3.6 % | +3.00% |
Europe
1.0
%
| 58 | 1.6 % | 62 | 1.0 % | +6.83% |
South America
0.4
%
| - | - | 21 | 0.4 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wei Dong Jiang
FOU | Founder | - | 01/09/01 |
Jun Zhu
CEO | Chief Executive Officer | 46 | 30/21/30 |
Wei Huang
PSD | President | 56 | 01/20/01 |
Wen Jie Zhang
CHM | Chairman | 57 | 01/19/01 |
Simon Hsu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Miao Jie Chen
CMP | Compliance Officer | 41 | - |
Ye Xing Yuan
BRD | Director/Board Member | 39 | 01/23/01 |
Jin Li
LAW | General Counsel | - | 13/21/13 |
Jing Li
PRN | Corporate Officer/Principal | - | - |
Ping Cao
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 15/13/15 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 24/18/24 |
Yi Fang Wu
BRD | Director/Board Member | 54 | 12/15/12 |
Rui Lin Song
BRD | Director/Board Member | 61 | 02/19/02 |
De Yong Wen
BRD | Director/Board Member | 52 | 28/22/28 |
Guo Ping Zhao
BRD | Director/Board Member | 75 | 02/19/02 |
Wen Jie Zhang
CHM | Chairman | 57 | 01/19/01 |
Rong Li Feng
CHM | Chairman | 49 | 21/20/21 |
Jun Zhu
CEO | Chief Executive Officer | 46 | 30/21/30 |
Ye Xing Yuan
BRD | Director/Board Member | 39 | 01/23/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 380,066,312 | 0 | 0 | 15.03 % |
Stock B | 1 | 163,428,541 | 81,687,447 ( 49.98 %) | 0 |
Company contact information
Shanghai Henlius Biotech, Inc.
Innov Tower 1801 Hongmei Road, Xuhui District
200233, Shanghai
+
http://www.henlius.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.05% | 90.45B | |
+3.95% | 41.45B | |
-10.51% | 33.57B | |
+60.58% | 25.73B | |
-20.09% | 14.73B | |
-8.92% | 12.82B | |
-11.46% | 11.7B | |
-43.05% | 11.44B | |
+5.17% | 8.79B |
- Stock Market
- Equities
- 2696 Stock
- SGBCF Stock
- Company Shanghai Henlius Biotech, Inc.